Onychomycosis Treatment Market Synopsis:
Onychomycosis Treatment Market Size Was Valued at USD 3.5 Billion in 2023, and is Projected to Reach USD 5.2 Billion by 2032, Growing at a CAGR of 4.5% From 2024-2032.
Onychomycosis also known as toenail or fingernail infection caused by different types of fungus: dermatophytes, non-dermatophyte molds as well as yeasts Candida. It manifests itself through discovery of yellow, thick and brittle nails, which bring about poor quality of life. The Onychomycosis Treatment market features multiple treatment options that are applied locally, orally and by laser, and multiplex strategies for optimizing treatment outcomes and reducing side effects. The market encompasses over the counters and prescription medicines, therefore has a wider patient reach. Ongoing improvements in treatment techniques and enhanced customer inconceiveness regarding nails have also further contributed to the growth of this market.
This report focuses on the Onychomycosis Treatment Market and its growth and expansion, which is characterized by increasing prevalence rates of the disease and increasing demand for efficient treatment solutions for patients, especially with specific comorbidities, including diabetes and peripheral vascular disease or the elderly population. The condition affects a wide of patients and has long treatment regimens all of which has elevated the demand for effective and amenable treatment. The reasons for this topical treatment are relative ease of application and virtually no side effects in most cases. At the same time, oral antifungal medicines of severe infections have remained more preferred recognizing that the comprehensive approach will suffice.
Trends with the growth of the market are also impacted by the technological development like the laser therapies non-invasive and fast-healing options. It has led to demand on aesthetics thus increasing the demand especially if in developed countries people would prefer a medical procedure. The market dynamics is also helped by the growth in healthcare networks and improved access to effective and costly treatments in emerging markets.
Onychomycosis Treatment Market Trend Analysis:
Technological Advancements in Laser Therapies
- Another very important trend occurring in the Onychomycosis Treatment Market at present is the increasing use of laser therapy. This innovative treatment delivers light-energy through the nail plate and effectively destructs fungi while sparing the surrounding tissues. Laser therapy also produces special interest due to the invasiveness of the treatment, its rate of effectiveness, and side effects as compared to long term drug administration. Additionally, the fact that it is emerging as an easily accessible treatment in dermatologists and podiatrists’ offices contributes to the idea that is a primary treatment as it becomes part of integrated treatment models.
Rising Prevalence Among Diabetic Populations
- Growing incidence of onychomycosis in patient s with diabetes mellitus is consider as new business opportunity in the market. Diabetes patients are more vulnerable to fungus attack because they have a weak immune system and their blood circulation is also impaired. Thus, early diagnosis and management are essential in order to avoid the development of complications as secondary infection and deterioration in mobility. Therefore, there is increased attention by both the manufacturers of the health care products and those providing treatment to come up with unique features that are specialized for diabetic patients thus boosting the market.
Onychomycosis Treatment Market Segment Analysis:
Onychomycosis Treatment Market Segmented on the basis of Disease Type, Treatment Type, Drug Class and region.
By Disease Type, Distal Subungual Onychomycosis Segment is Expected to Dominate the Market During the Forecast Period
- DSO is an affliction that begins at the distal portion of the nail bed and works its way up; it is the most prevalent type of onychomycosis. None the less, due to its common nature it is as a result of factors like exposure to moist areas and severe injuries to nails through which fungal spores penetrate. As a result of the high incidance of this disease type manufacturers have found it fit to come up with formulations that allow for better penetration into target sites and long acting, which translate to good market control.
- In the period under consideration, the DSO segment is expected to remain the largest mainly because of increasing demand, advancement in diagnostic procedures, and development of new drug delivery systems. The topical solutions advanced with better formulation technologies including penetration enhancers have made treatments better and have placed the segment in a better stand.
By Treatment Type, Laser Therapy segment Expected to Held the Largest Share
- It is anticipated that laser therapy will dominate the treatment type segment during the course of the forecast period. This novel treatment method where the use of focused light is used to treat fungal infections is slowly finding its way as an effective means of treating fungal infection without the need for surgery. More and more people are opting for this treatment due to the speed at which it is conducted, and the speed is usually faster than other methods that can be used in treating a disease.
- The advancement of laser technology and the enhancing penetration of laser devices in practices of dermatology and podiatry are also contributes to segment growth. Since these devices tend to become more affordable and more efficient as new technologies come up, there is likely going to be increased use of the laser therapy in the treatment of onychomycosis.
Onychomycosis Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- During 2023, the North America region held the largest share of the Onychomycosis Treatment Market and was responsible for 38.6%. The leading states include high incidence of fungal infection, well developed health care services, and good knowledge about nails. In addition, well established key market players, favourable reimbursement policies and availability of the new treatment modalities have added to the strong position of this region in this market. In one way or the other, the United States is a prime market for onychomycosis treatment innovation and product development.
Active Key Players in the Onychomycosis Treatment Market:
- Almirall (Spain)
- Bausch Health Companies Inc. (Canada)
- Cipher Pharmaceuticals (Canada)
- Galderma (Switzerland)
- GlaxoSmithKline plc (UK)
- Johnson & Johnson (USA)
- Kaken Pharmaceutical Co., Ltd. (Japan)
- Leo Pharma (Denmark)
- Medimetriks Pharmaceuticals, Inc. (USA)
- Moberg Pharma AB (Sweden)
- Novartis AG (Switzerland)
- Pfizer Inc. (USA)
- Sanofi (France)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Valeant Pharmaceuticals International, Inc. (Canada), and Other active Players
Key Industry Development of Onychomycosis Treatment Market:
In January 2025, Vanda Pharmaceuticals announced that the U.S. FDA has approved its Investigational New Drug (IND) application to evaluate VTR-297 for treating onychomycosis, a fungal nail infection also known as tinea unguium. This approval marks a significant step in advancing treatments for the condition, which affects millions worldwide. VTR-297's development underscores Vanda's commitment to innovative therapies in dermatology.
|
Global Onychomycosis Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.5 Billion |
|
Forecast Period 2024-32 CAGR: |
4.5% |
Market Size in 2032: |
USD 5.2 Billion |
|
Segments Covered: |
By Disease Type |
|
|
|
By Treatment Type |
|
||
|
By Drug Class |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Onychomycosis Treatment Market by By Disease Type (2018-2032)
4.1 Onychomycosis Treatment Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Distal Subungual Onychomycosis
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Proximal Subungual Onychomycosis
4.5 White Superficial Onychomycosis
4.6 Candidal Onychomycosis
4.7 Others
Chapter 5: Onychomycosis Treatment Market by By Treatment Type (2018-2032)
5.1 Onychomycosis Treatment Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Laser Therapy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Photodynamic Therapy
5.5 Drug Treatment
Chapter 6: Onychomycosis Treatment Market by By Drug Class (2018-2032)
6.1 Onychomycosis Treatment Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Allylamine
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Azole
6.5 Griseofulvin
6.6 Others
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Onychomycosis Treatment Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ALMIRALL (SPAIN)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 BAUSCH HEALTH COMPANIES INC. (CANADA)
7.4 CIPHER PHARMACEUTICALS (CANADA)
7.5 GALDERMA (SWITZERLAND)
7.6 GLAXOSMITHKLINE PLC (UK)
7.7 JOHNSON & JOHNSON (USA)
7.8 KAKEN PHARMACEUTICAL CO. LTD. (JAPAN)
7.9 LEO PHARMA (DENMARK)
7.10 MEDIMETRIKS PHARMACEUTICALS INC. (USA)
7.11 MOBERG PHARMA AB (SWEDEN)
7.12 NOVARTIS AG (SWITZERLAND)
7.13 PFIZER INC. (USA)
7.14 SANOFI (FRANCE)
7.15 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.16 VALEANT PHARMACEUTICALS INTERNATIONAL INC. (CANADA)
7.17 AND OTHER ACTIVE PLAYERS
Chapter 8: Global Onychomycosis Treatment Market By Region
8.1 Overview
8.2. North America Onychomycosis Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By By Disease Type
8.2.4.1 Distal Subungual Onychomycosis
8.2.4.2 Proximal Subungual Onychomycosis
8.2.4.3 White Superficial Onychomycosis
8.2.4.4 Candidal Onychomycosis
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By By Treatment Type
8.2.5.1 Laser Therapy
8.2.5.2 Photodynamic Therapy
8.2.5.3 Drug Treatment
8.2.6 Historic and Forecasted Market Size By By Drug Class
8.2.6.1 Allylamine
8.2.6.2 Azole
8.2.6.3 Griseofulvin
8.2.6.4 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Onychomycosis Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By By Disease Type
8.3.4.1 Distal Subungual Onychomycosis
8.3.4.2 Proximal Subungual Onychomycosis
8.3.4.3 White Superficial Onychomycosis
8.3.4.4 Candidal Onychomycosis
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By By Treatment Type
8.3.5.1 Laser Therapy
8.3.5.2 Photodynamic Therapy
8.3.5.3 Drug Treatment
8.3.6 Historic and Forecasted Market Size By By Drug Class
8.3.6.1 Allylamine
8.3.6.2 Azole
8.3.6.3 Griseofulvin
8.3.6.4 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Onychomycosis Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By By Disease Type
8.4.4.1 Distal Subungual Onychomycosis
8.4.4.2 Proximal Subungual Onychomycosis
8.4.4.3 White Superficial Onychomycosis
8.4.4.4 Candidal Onychomycosis
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By By Treatment Type
8.4.5.1 Laser Therapy
8.4.5.2 Photodynamic Therapy
8.4.5.3 Drug Treatment
8.4.6 Historic and Forecasted Market Size By By Drug Class
8.4.6.1 Allylamine
8.4.6.2 Azole
8.4.6.3 Griseofulvin
8.4.6.4 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Onychomycosis Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By By Disease Type
8.5.4.1 Distal Subungual Onychomycosis
8.5.4.2 Proximal Subungual Onychomycosis
8.5.4.3 White Superficial Onychomycosis
8.5.4.4 Candidal Onychomycosis
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By By Treatment Type
8.5.5.1 Laser Therapy
8.5.5.2 Photodynamic Therapy
8.5.5.3 Drug Treatment
8.5.6 Historic and Forecasted Market Size By By Drug Class
8.5.6.1 Allylamine
8.5.6.2 Azole
8.5.6.3 Griseofulvin
8.5.6.4 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Onychomycosis Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By By Disease Type
8.6.4.1 Distal Subungual Onychomycosis
8.6.4.2 Proximal Subungual Onychomycosis
8.6.4.3 White Superficial Onychomycosis
8.6.4.4 Candidal Onychomycosis
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By By Treatment Type
8.6.5.1 Laser Therapy
8.6.5.2 Photodynamic Therapy
8.6.5.3 Drug Treatment
8.6.6 Historic and Forecasted Market Size By By Drug Class
8.6.6.1 Allylamine
8.6.6.2 Azole
8.6.6.3 Griseofulvin
8.6.6.4 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Onychomycosis Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By By Disease Type
8.7.4.1 Distal Subungual Onychomycosis
8.7.4.2 Proximal Subungual Onychomycosis
8.7.4.3 White Superficial Onychomycosis
8.7.4.4 Candidal Onychomycosis
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By By Treatment Type
8.7.5.1 Laser Therapy
8.7.5.2 Photodynamic Therapy
8.7.5.3 Drug Treatment
8.7.6 Historic and Forecasted Market Size By By Drug Class
8.7.6.1 Allylamine
8.7.6.2 Azole
8.7.6.3 Griseofulvin
8.7.6.4 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Onychomycosis Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 3.5 Billion |
|
Forecast Period 2024-32 CAGR: |
4.5% |
Market Size in 2032: |
USD 5.2 Billion |
|
Segments Covered: |
By Disease Type |
|
|
|
By Treatment Type |
|
||
|
By Drug Class |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
The forecast period in the Onychomycosis Treatment Market research report is 2024-2032.
Almirall (Spain), Bausch Health Companies Inc. (Canada), Cipher Pharmaceuticals (Canada), Galderma (Switzerland), GlaxoSmithKline plc (UK), and Other active Players.
The Onychomycosis Treatment Market is segmented into Disease Type, Treatment Type, Drug Class and region. By Disease Type, the market is categorized into Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, Others. By Treatment Type, the market is categorized into Laser Therapy, Photodynamic Therapy, Drug Treatment. By Drug Class, the market is categorized into Allylamine, Azole, Griseofulvin, Others. By region, it is analyzed across • North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Onychomycosis also known as toenail or fingernail infection caused by different types of fungus: dermatophytes, non-dermatophyte molds as well as yeasts Candida. It manifests itself through discovery of yellow, thick and brittle nails, which bring about poor quality of life. The Onychomycosis Treatment market features multiple treatment options that are applied locally, orally and by laser, and multiplex strategies for optimizing treatment outcomes and reducing side effects.
Onychomycosis Treatment Market Size Was Valued at USD 3.5 Billion in 2023, and is Projected to Reach USD 5.2 Billion by 2032, Growing at a CAGR of 4.5% From 2024-2032.
